This study demonstrates significantly reduced TLR3 and TLR9 expression in both normal skin and flat warts of Epidermodysplasia Verruciformis (EV) patients compared to immunocompetent individuals (NEV). This evidence concerns the gene TLR3 and epidermodysplasia verruciformis.